n.broberg
TL2 · Faro
Contributes reviews on supplier material. Based in Faro.
Joined 2 February 2025 · last posted 3h
75 posts, newest first. Showing up to 150.
-
Request: tag synonyms surfaced in search Replied, post #28 · Meta › Feature requests · 28 Jul 2026 · 0 likes Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete. I would want a second opinion before relying on that.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #118 · Compounds › Semaglutide · 23 Jul 2026 · 0 likes Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #59 · Practice › Interactions · 23 Jul 2026 · 0 likes Post #58 is right about the mechanism and I think understates the practical bit. One caution on Delayed gastric emptying and oral: everything above assumes the…
-
Pooling trials with different estimands Replied, post #112 · Evidence › Meta-analyses · 20 Jul 2026 · 14 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
About the Reconstitution category Replied, post #3 · Practice › Reconstitution · 18 Jul 2026 · 3 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #82 · Analytics › Impurities & related substances · 16 Jul 2026 · 17 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #101 · Compounds › Semaglutide · 15 Jul 2026 · 0 likes Distinguishing three things in the molecular mass of semaglutide discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #24 · Start Here › How to Ask · 14 Jul 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #32 · Practice › Reconstitution · 13 Jul 2026 · 0 likes Filter needles are worth considering if you are drawing from a glass ampoule and are pointless overhead for a stoppered vial. The trade is dead volume against…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #41 · Pharmacology › Receptor biology · 11 Jul 2026 · 0 likes Worth separating two things that post #37 runs together. Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #23 · Clinical › Prescriber conversations · 10 Jul 2026 · 0 likes Post #22 put the caveat in the right place and I want to underline it. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually…
-
Does a peptide degrade silently, with no visual change? Replied, post #51 · Practice › Storage & stability · 19 Jun 2026 · 0 likes Two sentences on peptide and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is inferred…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #41 · Compounds › Tirzepatide · 17 Jun 2026 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #67 · Research Methods › N-of-1 designs · 10 May 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #89 · Devices › Syringes & needles · 5 May 2026 · 10 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #8 · Evidence › Journal club · 3 May 2026 · 3 likes Two people in this thread mean different things by STEP 8 and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing…
-
The best-written scientific paper you have read Replied, post #25 · Lounge › Off topic · 30 Apr 2026 · 10 likes The most useful reply I ever got about best-written scientific paper was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Tesamorelin has an approved indication — what that changes about the evidence Replied, post #4 · Compounds › Secretagogues & GH axis · 28 Apr 2026 · 3 likes The most useful single question to ask about any compound in this family is what the published human evidence actually consists of. In several cases the honest answer…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #15 · Clinical › Comorbidities · 10 Apr 2026 · 0 likes Reporting rather than recommending, on PCOS and metabolic overlap. What happened is above. Whether it should have is a different question and not one I am qualified to…
-
Follow-up: State-level differences that actually matter Replied, post #77 · Regional › North America · 8 Apr 2026 · 0 likes I changed my mind about State-level differences after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Constipation management, with a dietitian's contribution Replied, post #45 · Practice › Side effects · 27 Mar 2026 · 1 like The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #51 · Compounds › Tirzepatide · 20 Mar 2026 · 28 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #17 · Sourcing › Logistics · 14 Mar 2026 · 1 like Bookmarking this. I will come back when I have something worth adding.
-
Coming back to: When a red flag was a misunderstanding, and the retraction Started this topic · Sourcing › Red flags · 12 Mar 2026 · 1 like When a red flag was a misunderstanding, and the retraction I have a specific reason for asking rather than idle curiosity, and the context is below. Red flag — I have…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #95 · Clinical › Bloodwork · 8 Mar 2026 · 24 likes Answering the question post #91 raises rather than the one it answers. General information rather than advice about anyone's care. A single value outside a reference…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #31 · Practice › Reconstitution · 4 Mar 2026 · 25 likes Following this. I have the same question and no better information than the first post.
-
Contributing data without breaching anyone's privacy Replied, post #24 · Data & Tools › Datasets · 4 Mar 2026 · 27 likes Taking post #22 at face value and following it one step further. Second-hand on contributing data without breaching, so weight it accordingly — someone whose method I…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #31 · Analytics › Impurities & related substances · 24 Feb 2026 · 5 likes I read post #27 twice before replying, because I had assumed the opposite. Reporting thresholds matter: below a stated threshold, peaks are usually not reported at all.…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #130 · Sourcing › Independent verification · 20 Feb 2026 · 0 likes I read post #128 twice before replying, because I had assumed the opposite. I have no financial interest in anything named in this thread and I want to say so before I…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #53 · Practice › Dosing & titration · 17 Feb 2026 · 1 like Post #50 is right about the mechanism and I think understates the practical bit. Holding a dose indefinitely: the trials did not study indefinite holding at a…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #57 · Analytics › Mass spectrometry · 13 Feb 2026 · 17 likes Building on post #54 rather than restating it. A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish…
-
Preprint servers and what screening they do Replied, post #51 · Evidence › Preprints · 10 Feb 2026 · 13 likes Reading rather than answering, but this is the post I would point somebody at.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #62 · Documentation › Wiki requests · 30 Jan 2026 · 14 likes Documents that are mostly a worked example age better than documents that are mostly a summary, because the arithmetic does not change.
-
[2026 update] Availability by country, dated, with primary sources Replied, post #13 · Access › International · 16 Jan 2026 · 7 likes Coming back to post #11, because the follow-up matters more than the original answer. A first-hand dated account for a region with thin coverage is worth more here than…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #11 · Outcomes › Body composition · 8 Jan 2026 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #98 · Analytics › Home & field testing · 5 Jan 2026 · 0 likes Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap is fundamental rather than a matter of kit quality.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #31 · Pharmacology › Receptor biology · 28 Dec 2025 · 22 likes I had written a reply contradicting post #28 and deleted it. Here is what survived. In vitro potency and clinical potency are related by a long chain of assumptions. A…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #92 · Practice › Reconstitution · 8 Dec 2025 · 12 likes Where the Over-dilution discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #8 · Practice › Reconstitution · 22 Nov 2025 · 8 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Prescription requirements and telehealth models Replied, post #25 · Sourcing › Regulatory · 22 Nov 2025 · 3 likes Good question, well framed, and I would like to see it answered properly.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #125 · Start Here › How to Ask · 21 Nov 2025 · 12 likes The arithmetic in post #122 is right; the assumption feeding it is the part to check. Post the arithmetic you already did. Half the questions here are answered by…
-
Follow-up: Why appetite effects are mostly central Replied, post #72 · Pharmacology › Receptor biology · 20 Oct 2025 · 0 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #96 · Practice › Side effects · 26 Sep 2025 · 22 likes The version of nausea timeline that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and…
-
Why the timeline is on the right and not the left Replied, post #72 · Meta › Site feedback · 22 Sep 2025 · 0 likes That is a fair summary of where the discussion has got to.
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #108 · Compounds › Repair & healing peptides · 19 Aug 2025 · 27 likes Coming back to post #107, because the follow-up matters more than the original answer. TB-500 and thymosin beta-4 came up in a thread eighteen months ago and was…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #8 · Analytics › Method validation · 19 Aug 2025 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. What I can speak to on Robustness is narrow, so I will keep it narrow rather than generalising…
-
Specification in the result column: why that is a meaningful error Replied, post #20 · Analytics › COA interpretation · 18 Jul 2025 · 14 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Sodium, potassium and magnesium when intake drops Replied, post #64 · Nutrition & Training › Hydration & electrolytes · 18 Jul 2025 · 26 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures. The…
-
Coming back to: When "no data" is the complete and final answer Replied, post #30 · Compounds › Other compounds · 1 Jul 2025 · 2 likes Confirming post #29 from a second method, which matters more than confirming it from a second person. AOD-9604 is a fragment of human growth hormone and has been…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #71 · Outcomes › Progress reports · 26 Jun 2025 · 17 likes The reason 18-month record keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #8 · Devices › Pens & autoinjectors · 25 Jun 2025 · 15 likes Pen confusion between compounds: if you are using multiple pens or alternating pens, confirming you have the correct pen before injection prevents administration…
-
Sequence verification for an obscure compound: how it is done Replied, post #60 · Compounds › Other compounds · 12 Jun 2025 · 0 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #95 · Devices › Cold chain · 1 May 2025 · 0 likes Post #92 is right about the mechanism and I think understates the practical bit. I would keep Domestic fridge temperature mapping and the decision it usually gets used…
-
When "no data" is the complete and final answer Replied, post #161 · Compounds › Other compounds · 27 Apr 2025 · 1 like Post #157 describes the usual case. This is about the unusual one. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature,…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #3 · Compounds › Retatrutide · 17 Apr 2025 · 21 likes Picking up the opening post: that is the part I would want checked first. Anyone deciding on the basis of what is published should know that what is published is a…
-
Retatrutide dose escalation in the published trials Replied, post #73 · Compounds › Retatrutide · 1 Apr 2025 · 10 likes I read post #71 twice before replying, because I had assumed the opposite. Retatrutide is investigational. Material obtained outside a clinical trial is…
-
Coverage for the indication versus for the drug Replied, post #13 · Access › Insurance & coverage · 29 Mar 2025 · 4 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #94 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes Where I part company with post #90, and it is a narrow parting. Pattern across lots: a single result is a data point. Three or four results from the same supplier…
-
Reading order for a first week here, and what to skip until later Replied, post #37 · Start Here › Welcome · 15 Mar 2025 · 0 likes Reading order is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Domestic fridge temperature mapping: a cheap experiment Started this topic · Devices › Cold chain · 1 Mar 2025 · 50 likes Domestic fridge temperature mapping: a cheap experiment Writing it up because I had to work it out twice and would rather nobody else did. Collecting what is known…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #13 · Access › Pricing · 19 Feb 2025 · 11 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #41 · Analytics › Mass spectrometry · 29 Jan 2025 · 19 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #18 · Analytics › COA interpretation · 17 Jan 2025 · 1 like Where I part company with post #14, and it is a narrow parting. An itemised related-substances table with retention times says considerably more about the synthesis…
-
Recovery when intake is low: what to cut first Replied, post #82 · Nutrition & Training › Resistance training · 14 Jan 2025 · 26 likes Machine-based work is often better tolerated when energy is low and is not inferior for this purpose. Worth one more sentence than it usually gets.
-
Oxidation pathways for methionine and tryptophan Replied, post #21 · Analytics › Impurities & related substances · 27 Dec 2024 · 10 likes Adding the measurement that post #18 says would settle it. Oxidation pathways for methionine is worth one more sentence than it usually gets, and the sentence is the…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #52 · Compounds › Semaglutide · 22 Dec 2024 · 6 likes Adding the measurement that post #49 says would settle it. I would rather this thread reach "we do not know" about Molecular mass of semaglutide than reach a confident…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #21 · Compounds › Repair & healing peptides · 20 Dec 2024 · 0 likes TB-500 is a fragment rather than the whole thymosin beta-4 protein, and the two are used interchangeably in product descriptions when they should not be. The fragment…
-
Reading a supplementary appendix and finding the interesting part Replied, post #25 · Evidence › Trials · 17 Nov 2024 · 1 like Post #23 and I disagree about the size of the effect, not about the direction. One more thing on reading a supplementary appendix that took me far too long to see: the…
-
The topic list is dense — is that deliberate? Replied, post #48 · Meta › Site feedback · 5 Nov 2024 · 20 likes Post #46 describes the usual case. This is about the unusual one. Checked the topic list claim against the primary source this morning. It survives, with a narrower…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #65 · Clinical › Prescriber conversations · 26 Sep 2024 · 6 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #11 · Compounds › Oral incretins · 27 Aug 2024 · 17 likes An observation about orforglipron that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #6 · Analytics › Method validation · 11 Aug 2024 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #43 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes My understanding of four-week escalation interval is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep…
-
Journal club: FLOW and the renal composite, component by component Replied, post #9 · Evidence › Journal club · 8 Jul 2024 · 29 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Assessing a warm arrival: the decision process — one year on Replied, post #100 · Sourcing › Logistics · 1 Jun 2024 · 9 likes Second this, and I would have said it less carefully.